ArticleFrontiers in medicine2021

Novel Gene Signatures Predicting Primary Non-response to Infliximab in Ulcerative Colitis: Development and Validation Combining Random Forest With Artificial Neural Network.

Jing Feng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.